Recital 2, Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 Decembe…

In forcesince 15 Dec 2010

Pharmacovigilance rules are necessary for the protection of public health in order to prevent, detect and assess adverse reactions to medicinal products for human use placed on the Union market, as the full safety profile of medicinal products for human use can be known only after they have been placed on the market.